168 related articles for article (PubMed ID: 36342979)
1. Motives for using new psychoactive substances in three groups of Polish users: nightlife, marginalised and active on the In.
Wieczorek Ł; Dąbrowska K; Bujalski M
Psychiatr Pol; 2022 Jun; 56(3):453-470. PubMed ID: 36342979
[TBL] [Abstract][Full Text] [Related]
2. Negative consequences of novel psychoactive substances use among the Polish users.
Wieczorek Ł; Bujalski M; Dąbrowska K
Psychiatr Pol; 2021 Apr; 55(2):447-469. PubMed ID: 34365491
[TBL] [Abstract][Full Text] [Related]
3. Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.
Benschop A; Urbán R; Kapitány-Fövény M; Van Hout MC; Dąbrowska K; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Silva JP; Wieczorek Ł; Werse B; Bujalski M; Korf D; Demetrovics Z
J Psychopharmacol; 2020 Jun; 34(6):600-611. PubMed ID: 32043399
[TBL] [Abstract][Full Text] [Related]
4. Novel psychoactive substances (NPS) - knowledge and expe riences of drug users from Hungary, Poland, the UK and the USA.
Pisarska A; Deluca P; Demetrovics Z; Moskalewicz J; ReDNet G
Neuropsychopharmacol Hung; 2019 Dec; 21(4):152-163. PubMed ID: 32015192
[TBL] [Abstract][Full Text] [Related]
5. Awareness of users and motivational factors for using new psychoactive substances in Belgium.
Simonis S; Canfyn M; Van Dijck A; Van Havere T; Deconinck E; Blanckaert P; Gremeaux L
Harm Reduct J; 2020 Jul; 17(1):52. PubMed ID: 32711526
[TBL] [Abstract][Full Text] [Related]
6. Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.
Van Hout MC; Benschop A; Bujalski M; Dąbrowska K; Demetrovics Z; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Korf D; Silva JP; Wieczorek Ł; Werse B
Int J Ment Health Addict; 2018; 16(2):480-495. PubMed ID: 29674947
[TBL] [Abstract][Full Text] [Related]
7. New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary.
Csák R; Szécsi J; Kassai S; Márványkövi F; Rácz J
Int J Drug Policy; 2020 Nov; 85():102639. PubMed ID: 31911024
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
[TBL] [Abstract][Full Text] [Related]
9. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
[TBL] [Abstract][Full Text] [Related]
10. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
[TBL] [Abstract][Full Text] [Related]
11. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior.
Vreeker A; van der Burg BG; van Laar M; Brunt TM
Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739
[TBL] [Abstract][Full Text] [Related]
12. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
Soussan C; Andersson M; Kjellgren A
Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
[TBL] [Abstract][Full Text] [Related]
13. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
Champion KE; Teesson M; Newton NC
Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties.
da Cunha KF; Oliveira KD; Cardoso MS; Arantes ACF; Coser PHP; Lima LN; Maluf ACS; Comis MAC; Huestis MA; Costa JL
Drug Alcohol Depend; 2021 Oct; 227():108962. PubMed ID: 34461412
[TBL] [Abstract][Full Text] [Related]
15. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
Soussan C; Kjellgren A
Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
[TBL] [Abstract][Full Text] [Related]
16. Identifying problematic Internet users: development and validation of the Internet Motive Questionnaire for Adolescents (IMQ-A).
Bischof-Kastner C; Kuntsche E; Wolstein J
J Med Internet Res; 2014 Oct; 16(10):e230. PubMed ID: 25299174
[TBL] [Abstract][Full Text] [Related]
17. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
Sande M
Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
[TBL] [Abstract][Full Text] [Related]
19. Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study.
Van Dyck E; Ponnet K; Van Havere T; Hauspie B; Dirkx N; Schrooten J; Waldron J; Grabski M; Freeman TP; Curran HV; De Neve J
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767188
[TBL] [Abstract][Full Text] [Related]
20. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
Van Hout MC; Hearne E
Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]